Elder Granger - 07 Jun 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 07 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2023, 18:56:37 UTC
Prior SEC filing: 18 May 2023
Next SEC filing: 31 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Mark Heinen, Attorney-in-Fact

Key filing fact

Elder Granger filed Form 4 for Better Therapeutics, Inc. on 09 Jun 2023.

Key facts

This page summarizes Elder Granger's Form 4 filing for Better Therapeutics, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2023, 18:56.

Change

Previous filing in this sequence was filed on 18 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BTTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 07 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $0.7700
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023.